{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T19:45:28Z","timestamp":1760298328031},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2011,1,18]],"date-time":"2011-01-18T00:00:00Z","timestamp":1295308800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2011,1,18]],"date-time":"2011-01-18T00:00:00Z","timestamp":1295308800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Treat Options Neurol"],"published-print":{"date-parts":[[2011,4]]},"DOI":"10.1007\/s11940-011-0114-0","type":"journal-article","created":{"date-parts":[[2011,1,17]],"date-time":"2011-01-17T05:08:38Z","timestamp":1295240918000},"page":"131-142","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Inflammatory Demyelinating Neuropathies"],"prefix":"10.1007","volume":"13","author":[{"given":"Glenn","family":"Lopate","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alan","family":"Pestronk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,1,18]]},"reference":[{"key":"114_CR1","volume-title":"Guillain-Barr\u00e9 Syndrome","author":"AH Ropper","year":"1991","unstructured":"Ropper AH, Wijdicks EFM, Truax BT: Guillain-Barr\u00e9 Syndrome. Philadelphia: Davis; 1991."},{"key":"114_CR2","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1016\/B978-0-7216-9491-7.50102-2","volume-title":"Peripheral neuropathy","author":"AF Hahn","year":"2005","unstructured":"Hahn AF, Hartung H-P, Dyck PJ: Chronic inflammatory demyelinating polyradiculoneuropathy. In Peripheral neuropathy, edn 4th. By Dyck PJ, Thomas PK. Philadelphia: Elsevier Saunders; 2005:2221\u20132253.","edition":"4"},{"key":"114_CR3","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1002\/1097-4598(200101)24:1<54::AID-MUS6>3.0.CO;2-9","volume":"24","author":"S Kuwabara","year":"2001","unstructured":"Kuwabara S, Mori M, Ogawara K, et al.: Intravenous immunoglobulin therapy for Guillain-Barr\u00e9 syndrome with IgG anti-GM1 antibody. Muscle Nerve 2001, 24:54\u201358.","journal-title":"Muscle Nerve"},{"key":"114_CR4","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1002\/1531-8249(200003)47:3<314::AID-ANA6>3.0.CO;2-C","volume":"47","author":"N Yuki","year":"2000","unstructured":"Yuki N, Ang CE, Koga M, et al.: Clinical features and response to treatment in Guillain-Barr\u00e9 syndrome associates with antibodies to GM1b ganglioside. Ann Neurol 2000, 47:314\u2013321.","journal-title":"Ann Neurol"},{"key":"114_CR5","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1212\/WNL.48.2.321","volume":"48","author":"KC Gorson","year":"1997","unstructured":"Gorson KC, Allam G, Ropper AH: Chronic inflammatory demyelinating polyneuropathy: clinical features and response to treatment in 67 consecutive patients with and without a monoclonal gammopathy. Neurology 1997, 48:321\u2013328.","journal-title":"Neurology"},{"key":"114_CR6","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1093\/brain\/118.2.359","volume":"118","author":"Z Simmons","year":"1995","unstructured":"Simmons Z, Albers JW, Bromberg MB, Feldman EL: Long-term follow-up of patients with chronic inflammatory demyelinating polyradiculoneuropathy, without and with monoclonal gammopathy. Brain 1995, 118:359\u2013368.","journal-title":"Brain"},{"key":"114_CR7","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.1056\/NEJM199111213252105","volume":"325","author":"PJ Dyck","year":"1991","unstructured":"Dyck PJ, Low PA, Windebank AJ, et al.: Plasma exchange in polyneuropathy associated with monoclonal gammopathy of undetermined significance. N Engl J Med 1991, 325:1482\u20131486.","journal-title":"N Engl J Med"},{"key":"114_CR8","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1136\/jnnp.2009.202796","volume":"81","author":"A Pestronk","year":"2010","unstructured":"Pestronk A, Chuquilin M, Choksi R: Motor neuropathies and serum IgM binding to NS6S heparin disaccharide or GM1 ganglioside. J Neurol Neurosurg Psychiatry 2010, 81:726\u2013730.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"114_CR9","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1016\/S0140-6736(84)91341-2","volume":"1","author":"RJ Greenwood","year":"1984","unstructured":"Greenwood RJ, Newsom-Davis J, Hughes RAC, et al.: Controlled trial of plasma exchange in acute inflammatory polyradiculoneuropathy. Lancet 1984, 1:877\u2013879.","journal-title":"Lancet"},{"key":"114_CR10","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1212\/WNL.35.8.1096","volume":"35","author":"The Guillain-Barr\u00e9 Syndrome Study Group","year":"1985","unstructured":"The Guillain-Barr\u00e9 Syndrome Study Group: Plasmapheresis and acute Guillain-Barr\u00e9 syndrome. Neurology 1985, 35:1096\u20131104.","journal-title":"Neurology"},{"key":"114_CR11","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1016\/S0140-6736(84)90819-5","volume":"2","author":"PO Osterman","year":"1984","unstructured":"Osterman PO, Fagius J, Lundemo G, et al.: Beneficial effects of plasma exchange in acute inflammatory polyradiculoneuropathy. Lancet 1984, 2:1296\u20131299.","journal-title":"Lancet"},{"key":"114_CR12","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1002\/ana.410220612","volume":"22","author":"French Cooperative Group on Plasma Exchange in Guillain-Barr\u00e9 syndrome","year":"1987","unstructured":"French Cooperative Group on Plasma Exchange in Guillain-Barr\u00e9 syndrome: Efficiency of plasma exchange in Guillain-Barr\u00e9 syndrome: role of replacement fluids. Ann Neurol 1987, 22:753\u2013761.","journal-title":"Ann Neurol"},{"key":"114_CR13","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1002\/ana.410410304","volume":"41","author":"French Cooperative Group on Plasma Exchange in Guillain-Barr\u00e9 Syndrome","year":"1997","unstructured":"French Cooperative Group on Plasma Exchange in Guillain-Barr\u00e9 Syndrome: Appropriate number of plasma exchanges in Guillain-Barr\u00e9 Syndrome. Ann Neurol 1997, 41:298\u2013306.","journal-title":"Ann Neurol"},{"key":"114_CR14","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1056\/NEJM199204233261705","volume":"326","author":"FGA van der Mech\u00e9","year":"1992","unstructured":"van der Mech\u00e9 FGA, Schmitz PIM, Dutch Guillain-Barr\u00e9 Study Group: A randomized trial comparing intravenous immune globulin and plasma exchange in Guillain-Barr\u00e9 syndrome. N Engl J Med 1992, 326:1123\u20131129.","journal-title":"N Engl J Med"},{"key":"114_CR15","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1212\/WNL.46.1.100","volume":"46","author":"V Bril","year":"1996","unstructured":"Bril V, Ilse WK, Pearce R, Dhanani A, Sutton D, Kong K: Pilot trial of immunoglobulin versus plasma exchange in patients with Guillain-Barr\u00e9 syndrome. Neurology 1996, 46:100\u2013103.","journal-title":"Neurology"},{"key":"114_CR16","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/S0140-6736(96)09095-2","volume":"349","author":"PSGBS-Study Group","year":"1997","unstructured":"PSGBS-Study Group: Randomised trial of plasma exchange, intravenous immunoglobulin, and combined treatments in Guillain-Barr\u00e9 syndrome. Lancet 1997, 349:225\u2013230.","journal-title":"Lancet"},{"key":"114_CR17","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1002\/ana.410110205","volume":"11","author":"PJ Dyck","year":"1982","unstructured":"Dyck PJ, O\u2019Brien PC, Oviatt KF, et al.: Prednisone improves chronic inflammatory polyradiculoneuropathy more than no treatment. Ann Neurol 1982, 11:136\u2013141.","journal-title":"Ann Neurol"},{"key":"114_CR18","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1136\/jnnp.62.4.388","volume":"62","author":"DSM Molenaar","year":"1997","unstructured":"Molenaar DSM, van Doorn PA, Vermeulen M: Pulsed high dose dexamethasone treatment in chronic inflammatory demyelinating polyneuropathy: a pilot study. J Neurol Neurosurg Psychiatry 1997, 62:388\u2013390.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"114_CR19","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1001\/archneur.62.2.249","volume":"62","author":"G Lopate","year":"2005","unstructured":"Lopate G, Pestronk A, Al-Lozi M: Treatment of chronic inflammatory demyelinating polyneuropathy with high-dose intermittent intravenous methylprednisolone. Arch Neurol 2005, 62:249\u2013254.","journal-title":"Arch Neurol"},{"key":"114_CR20","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1001\/archneur.65.11.1460","volume":"65","author":"SA Muley","year":"2008","unstructured":"Muley SA, Kelkar P, Parry GJ: Treatment of chronic inflammatory demyelinating polyneuropathy with pulsed oral steroids. Arch Neurol 2008, 65:1460\u20131464.","journal-title":"Arch Neurol"},{"key":"114_CR21","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/S1474-4422(10)70021-1","volume":"9","author":"IN van Schaik","year":"2010","unstructured":"van Schaik IN, Eftimov F, van Doorn PA, et al.: Pulsed high-dose dexamethasone versus standard prednisolone treatment for chronic inflammatory demyelinating polyradiculoneuropathy (PREDICT study): a double-blind, randomised, controlled trial. Lancet Neurol 2010, 9:245\u2013253.","journal-title":"Lancet Neurol"},{"key":"114_CR22","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1136\/jnnp.56.1.36","volume":"56","author":"M Vermeulen","year":"1993","unstructured":"Vermeulen M, van Doorn PA, Brand A, Strengers PF, Jennekens FG, Busch HF: Intravenous immunoglobulin treatment in patients with chronic inflammatory demyelinating polyneuropathy: a double blind, placebo controlled study. J Neurol Neurosurg Psychiatry 1993, 56:36\u201339.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"114_CR23","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1002\/ana.410360607","volume":"36","author":"PJ Dyck","year":"1994","unstructured":"Dyck PJ, Litchy WJ, Kratz KM, et al.: A plasma exchange versus immune globulin infusion trial in chronic inflammatory demyelinating polyradiculoneuropathy. Ann Neurol 1994, 36:838\u2013845.","journal-title":"Ann Neurol"},{"key":"114_CR24","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1093\/brain\/119.4.1067","volume":"119","author":"AF Hahn","year":"1996","unstructured":"Hahn AF, Bolton CF, Zochodne D, Feasby TE: Intravenous immunoglobulin treatment in chronic inflammatory demyelinating polyneuropathy. A double-blind, placebo-controlled, cross-over study. Brain 1996, 119:1067\u20131077.","journal-title":"Brain"},{"key":"114_CR25","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1007\/BF00868527","volume":"243","author":"N Thompson","year":"1996","unstructured":"Thompson N, Choudhary P, Hughes RAC, Quinlivan RM: A novel trial design to study the effect of intravenous immunoglobulin in chronic inflammatory demyelinating polyradiculoneuropathy. J Neurol 1996, 243:280\u2013285.","journal-title":"J Neurol"},{"key":"114_CR26","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1212\/WNL.56.4.445","volume":"56","author":"JR Mendell","year":"2001","unstructured":"Mendell JR, Barohn RJ, Freimer ML, et al.: Randomized controlled trial of IVIg in untreated chronic inflammatory demyelinating polyradiculoneuropathy. Neurology 2001, 56:445\u2013449.","journal-title":"Neurology"},{"key":"114_CR27","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1002\/ana.1088","volume":"50","author":"R Hughes","year":"2001","unstructured":"Hughes R, Bensa S, Willison HJ, et al.: Randomized controlled trial of intravenous immunoglobulin versus oral prednisolone in chronic inflammatory demyelinating polyradiculoneuropathy. Ann Neurol 2001, 50:195\u2013201.","journal-title":"Ann Neurol"},{"key":"114_CR28","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/S1474-4422(07)70329-0","volume":"7","author":"RA Hughes","year":"2008","unstructured":"Hughes RA, Donofrio P, Bril V, ICE Study Group, et al.: Intravenous immune globulin (10% caprylate-chromatography purified) for the treatment of chronic inflammatory demyelinating polyradiculoneuropathy (ICE Study): a randomised placebo-controlled trial. Lancet Neurol 2008, 7:136\u2013144.","journal-title":"Lancet Neurol"},{"key":"114_CR29","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1093\/brain\/119.4.1055","volume":"119","author":"AF Hahn","year":"1996","unstructured":"Hahn AF, Bolton CF, Pillay N, et al.: Plasma exchange in chronic inflammatory demyelinating polyradiculoneuropathy. A double blind, sham-controlled, crossover study. Brain 1996, 119:1055\u20131066.","journal-title":"Brain"},{"key":"114_CR30","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1056\/NEJM198602203140801","volume":"314","author":"PJ Dyck","year":"1986","unstructured":"Dyck PJ, Daube J, O\u2019Brien P, et al.: Plasma exchange in chronic inflammatory demyelinating polyradiculoneuropathy. N Engl J Med 1986, 314:461\u2013465.","journal-title":"N Engl J Med"},{"key":"114_CR31","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1542\/peds.2004-1324","volume":"116","author":"R Korinthenberg","year":"2005","unstructured":"Korinthenberg R, Schessl J, Kirschner J, Monting JS: Intravenously administered immunoglobulin in the treatment of childhood Guillain-Barr\u00e9 syndrome: a randomized trial. Pediatrics 2005, 116:8\u201314.","journal-title":"Pediatrics"},{"key":"114_CR32","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.pharmthera.2004.04.002","volume":"102","author":"MC Dalakas","year":"2004","unstructured":"Dalakas MC: The use of intravenous immunoglobulin in the treatment of autoimmune neuromuscular diseases: evidence-based indications and safety profile. Pharmacol Ther 2004, 102:177\u2013193.","journal-title":"Pharmacol Ther"},{"key":"114_CR33","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1002\/(SICI)1098-1101(1999)14:3<107::AID-JCA1>3.0.CO;2-3","volume":"14","author":"S Nagpal","year":"1999","unstructured":"Nagpal S, Benstead T, Shumak K, Rock G, Brown M, Anderson DR: Treatment of Guillain-Barr\u00e9 syndrome: a cost-effectiveness analysis. J Clin Apher 1999, 14:107\u2013113.","journal-title":"J Clin Apher"},{"key":"114_CR34","first-page":"109","volume-title":"Guillain-Barr\u00e9 syndrome: from diagnosis to recovery","year":"2007","unstructured":"Parry GJ, Steinberg JS (eds.): Guillain-Barr\u00e9 syndrome: from diagnosis to recovery. Saint Paul: AAN; 2007:109\u2013146."},{"key":"114_CR35","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1212\/WNL.35.8.1173","volume":"35","author":"PJ Dyck","year":"1985","unstructured":"Dyck PJ, O\u2019Brien P, Swanson C, et al.: Combined azathioprine and prednisone in chronic inflammatory demyelinating polyneuropathy. Neurology 1985, 35:1173\u20131176.","journal-title":"Neurology"},{"key":"114_CR36","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1002\/ana.410090719","volume":"9","author":"MC Dalakas","year":"1981","unstructured":"Dalakas MC, Engel WK: Chronic relapsing (dysimmune) polyneuropathy: pathogenesis and treatment. Ann Neurol 1981, 9:134\u2013145.","journal-title":"Ann Neurol"},{"key":"114_CR37","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1002\/(SICI)1097-4598(199804)21:4<454::AID-MUS3>3.0.CO;2-8","volume":"21","author":"MH Barnett","year":"1998","unstructured":"Barnett MH, Pollard JD, Davies L, et al.: Cyclosporine A in resistant chronic inflammatory demyelinating polyradiculoneuropathy. Muscle Nerve 1998, 21:454\u2013460.","journal-title":"Muscle Nerve"},{"key":"114_CR38","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1136\/jnnp.60.2.185","volume":"60","author":"W Mahattanakul","year":"1996","unstructured":"Mahattanakul W, Crawford TO, Griffin JW, et al.: Treatment of chronic inflammatory demyelinating polyneuropathy with cyclosporin-A. J Neurol Neurosurg Psychiatry 1996, 60:185\u2013187.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"114_CR39","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1212\/01.WNL.0000134676.05850.C0","volume":"63","author":"KC Gorson","year":"2004","unstructured":"Gorson KC, Amato AA, Ropper AH: Efficacy of mycophenolate mofetil in patients with chronic immune demyelinating polyneuropathy. Neurology 2004, 63:715\u2013717.","journal-title":"Neurology"},{"key":"114_CR40","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1136\/jnnp.2009.177576","volume":"81","author":"G Bedi","year":"2010","unstructured":"Bedi G, Brown A, Tong T, Sharma R: Chronic inflammatory demyelinating polyneuropathy responsive to mycophenolate mofetil therapy. J Neurol Neurosurg Psychiatry 2010, 81:634\u2013636.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"114_CR41","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1212\/WNL.51.6.1735","volume":"51","author":"JL Good","year":"1998","unstructured":"Good JL, Chehrenama M, Mayer RF, et al.: Pulse cyclophosphamide therapy in chronic inflammatory demyelinating polyneuropathy. Neurology 1998, 51:1735\u20131738.","journal-title":"Neurology"},{"key":"114_CR42","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1111\/j.1085-9489.2005.10104.x","volume":"10","author":"DE Gladstone","year":"2005","unstructured":"Gladstone DE, Prestrud AA, Brannagan 3rd TH: High dose cyclophosphamide results in long-term disease remission with restoration of a normal quality of life in patients with severe refractory chronic inflammatory demyelinating polyneuropathy. J Peripher Nerve Syst 2005, 10:11\u201316.","journal-title":"J Peripher Nerve Syst"},{"key":"114_CR43","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1002\/mus.20909","volume":"37","author":"DH Lee","year":"2008","unstructured":"Lee DH, Linker RA, Paulus W, et al.: Subcutaneous immunoglobulin infusion: a new therapeutic option in chronic inflammatory demyelinating polyneuropathy. Muscle Nerve 2008, 37:406\u2013409.","journal-title":"Muscle Nerve"},{"key":"114_CR44","first-page":"176","volume":"13","author":"L Magy","year":"2008","unstructured":"Magy L: Subcutaneous injections of polyvalent immunoglobulins as a maintenance therapy for intravenous immunoglobulin-responsive patients with chronic inflammatory demyelinating polyneuropathy [abstract]. J Peripher Nerv Syst 2008, 13:176.","journal-title":"J Peripher Nerv Syst"},{"key":"114_CR45","doi-asserted-by":"crossref","unstructured":"Benedetti L, Briani C, Franciotta D, et al.: Rituximab in patients with chronic inflammatory demyelinating polyradiculoneuropathy; a report of 13 cases and review of the literature.\n                              J Neurol Neurosurg Psychiatry 2010 Jul 16 (Epub ahead of print). This is the largest series of refractory CIDP patients to receive rituximab, many with concomitant hematologic disease (paraproteinemia or lymphoma). Of 13 patients, 9 responded and no major adverse events were noted.","DOI":"10.1136\/jnnp.2009.188912"},{"key":"114_CR46","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1007\/s00415-009-5437-3","volume":"257","author":"EA Marsh","year":"2010","unstructured":"Marsh EA, Hirst CL, Llewelyn JG, et al.: Alemtuzumab in the treatment of IVIG-dependent chronic inflammatory demyelinating polyneuropathy. J Neurol 2010, 257:913\u2013919.","journal-title":"J Neurol"},{"key":"114_CR47","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1111\/j.1529-8027.2009.00221.x","volume":"14","author":"M Mahdi-Rogers","year":"2009","unstructured":"Mahdi-Rogers M, Kazmi M, Ferner R, et al.: Autologous peripheral blood stem cell transplantation for chronic acquired demyelinating neuropathy. J Periph Nerve Syst 2009, 14:118\u2013124.","journal-title":"J Periph Nerve Syst"},{"key":"114_CR48","doi-asserted-by":"publisher","first-page":"1802","DOI":"10.1212\/01.wnl.0000277266.53449.8b","volume":"69","author":"Y Oyama","year":"2007","unstructured":"Oyama Y, Sufit R, Loh Y, et al.: Nonmyeloablative autologous hematopoietic stem cell transplantation for refractory CIDP. Neurology 2007, 69:1802\u20131803.","journal-title":"Neurology"},{"key":"114_CR49","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1111\/j.1468-1331.2007.01615.x","volume":"14","author":"P Remenyi","year":"2007","unstructured":"Remenyi P, Masszi T, Borbenyi Z, et al.: CIDP cured by allogeneic hematopoietic stem cell transplantation. Eur J Neurol 2007, 14:e1\u2013e2.","journal-title":"Eur J Neurol"},{"key":"114_CR50","doi-asserted-by":"publisher","first-page":"241","DOI":"10.3109\/00365549509019016","volume":"27","author":"N G\u00fcrses","year":"1995","unstructured":"G\u00fcrses N, Uysal S, \u00c7etinkaya F, \u00cdslek \u00cd, Kalayci AG: Intravenous immunoglobulin treatment in children with Guillain-Barr\u00e9 syndrome. Scand J Infect Dis 1995, 27:241\u2013243.","journal-title":"Scand J Infect Dis"},{"key":"114_CR51","first-page":"223","volume":"16","author":"R Wang","year":"2001","unstructured":"Wang R, Feng A, Sun W, Wen Z: Intravenous immunoglobulin in children with Guillain-Barr\u00e9 syndrome. J Appl Clin Ped 2001, 16:223\u2013224.","journal-title":"J Appl Clin Ped"},{"key":"114_CR52","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1212\/WNL.47.1.98","volume":"47","author":"Y Nevo","year":"1996","unstructured":"Nevo Y, Pestronk A, Kornberg AJ, et al.: Childhood chronic inflammatory demyelinating neuropathies: clinical course and long-term follow-up. Neurology 1996, 47:98\u2013102.","journal-title":"Neurology"},{"key":"114_CR53","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/S0887-8994(00)00237-X","volume":"24","author":"AM Connolly","year":"2001","unstructured":"Connolly AM: Chronic inflammatory demyelinating polyneuropathy in childhood. Pediatr Neurol 2001, 24:177\u2013182.","journal-title":"Pediatr Neurol"},{"key":"114_CR54","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1016\/S0960-8966(00)00119-X","volume":"10","author":"MM Ryan","year":"2000","unstructured":"Ryan MM, Grattan-Smith PJ, Procopis PG, Morgan G, Ouvrier RA: Childhood chronic inflammatory demyelinating polyneuropathy: clinical course long-term outcome. Neuromuscul Disord 2000, 10:398\u2013406.","journal-title":"Neuromuscul Disord"},{"key":"114_CR55","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/S0022-510X(97)00216-5","volume":"154","author":"N Hattori","year":"1998","unstructured":"Hattori N, Ichimura M, Aoki S, et al.: Clinicopathological features of chronic inflammatory demyelinating polyradiculoneuropathy in childhood. J Neurol Sci 1998, 154:66\u201371.","journal-title":"J Neurol Sci"}],"container-title":["Current Treatment Options in Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11940-011-0114-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11940-011-0114-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11940-011-0114-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11940-011-0114-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,29]],"date-time":"2022-07-29T11:57:16Z","timestamp":1659095836000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11940-011-0114-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,1,18]]},"references-count":55,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,4]]}},"alternative-id":["114"],"URL":"https:\/\/doi.org\/10.1007\/s11940-011-0114-0","relation":{},"ISSN":["1092-8480","1534-3138"],"issn-type":[{"value":"1092-8480","type":"print"},{"value":"1534-3138","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,1,18]]},"assertion":[{"value":"18 January 2011","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}